https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Biohackathon COVID-19-BH20 via the Internet

31 de March de 2020

The objective of COVID-19-BH20 is to create and work on tools for the analysis of COVID-19. The biohackathon will lead to more easily accessible protein data, protocols, detection kits, predictions. Policy change will also be driven when it comes to non-public or hard-to-access data because we face such challenges. The biohackathon is about applying free […]

Read more →

Suspension of IDIVAL aid terms

Based on Royal Decree 463/2020, of March 14, declaring the state of alarm for the management of the health crisis situation caused by COVID-19, and in application of its fourth additional provision regarding prescription and expiration terms, the deadlines established for the call for the IDIVAL 2020 Biosanitary Revitalizing Plan, are suspended during the validity […]

Read more →

Call Express CaixaImpulse COVID-19

CaixaImpulse COVID-19 call seeks to support projects with results, including preliminary ones, of scientific research or with strategies and technologies in additional transfer stages that can have a significant impact on the beneficiaries. The call is aimed at Universities, university foundations, research and transfer centers, technology centers, hospitals, hospital foundations and non-profit institutions whose main […]

Read more →

Serum transferrin is an independent predictor of mortality in severe alcoholic hepatitis

10 de March de 2020

Alcoholic hepatitis is a clinical picture that occurs when high amounts of alcohol are consumed in people who already have a regular consumption of it for a long time. It is an entity that in severe cases carries a very high mortality, in certain circumstances it reaches more than half of the cases in less […]

Read more →

Pfizer Foundation Innovation Awards for young researchers

The Pfizer Foundation Scientific Innovation Awards want to recognize Spanish researchers up to 40 years old whose works have been published in scientific journals and cited in the Science Citation Index throughout 2019.  The best article related to scientific research will be awarded, in its basic and clinical categories, in the field of biomedicine and […]

Read more →

6th edition of the NEXT-Val Call for young researchers

The NEXT-VAL call promotes the development of translational research projects in the biosanitary environment of Cantabria, led by leading emerging researchers who have never accessed as such a competitive access aid. Requirements of the principal investigator: It will be necessary to have a principal investigator who has a labor, official or statutory relationship with the […]

Read more →

Canceled Next Session Progress Reports

9 de March de 2020

On March 11, the third session will take place within the IV Progress Report of the Valdecilla program, which will feature the presentations of Esther Setién and Veronica Pulito. CANCELLED “ Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort” Speaker: Esther Setién Suero Esther Setién is a doctor […]

Read more →

Analysis of the BAFF cytokine as a biomarker potential

The IDIVAL Transplant and Autoimmunity group, belonging to the Kidney Disease Research Network (REDINREN) funded by the ISCIII with FEDER funds, has published a recent work in its biomarker line of work associated with the clinical evolution of Renal Transplant. Renal transplantation is the best treatment for patients with advanced chronic kidney disease compared to […]

Read more →

Researchers at IDIVAL and CNIO find the molecular regulation that allows the skin to be continuously exposed to the sun

2 de March de 2020

The Cell Cycle, Determining Stem Cells and Cancer research group of the Valdecilla Health Research Institute (IDIVAL), led by Dr. Alberto Gandarillas, has just published a paper that includes the molecular regulation that makes it possible for epithelial cells such as skin epidermis do not die against continuous carcinogens such as sunlight. This discovery has […]

Read more →

Analysis of genotyping methodologies to detect RAS mutations

It is currently known that those patients with metastatic colorectal cancer (CCRm) whose tumors have mutations at the level of certain genes involved in the EGFR receptor pathway (HER-1), such as the RAS gene (KRAS or NRAS exons 2,3 and 4 ), do not benefit from therapy with monoclonal antibodies with antiEGFR activity (Cetuximab or […]

Read more →